QuantumScape restructures PowerCo deal with $75.4M milestone plan and updated tech roadmap
QS is trading near its 52-week low of $5.645 (5.4% above the low).
Summary
QuantumScape amended its collaboration agreement with PowerCo, introducing a $75.4 million milestone-based payment structure and updated technical milestones focused on automotive cell development and larger format cells.
Key Events · M&A and Partnerships · QS
-
Collaboration Amended with PowerCo
QuantumScape and PowerCo amended their July 2025 collaboration agreement, replacing the prior cost-reimbursement structure with milestone-based payments totaling up to $75.4 million, inclusive of amounts already paid.
-
New Program Scope and Milestones
The amendment introduces Statement of Work No. 2 (SOW-2), focusing on automotive cell development, larger format cells, and QuantumScape's future technology roadmap, with updated technical specifications and milestones.
-
Demonstration Fleet Provision
PowerCo may produce up to 500 MWh of battery cells for demonstration fleets of automotive vehicles, at its discretion, potentially before start of production.
-
Financial Impact
The $75.4 million maximum aggregate payments provide non-dilutive funding for QuantumScape's development efforts over the next two years, replacing the previous open-ended cost reimbursement.
Analysis · QS · Manufacturing
QuantumScape restructured its key collaboration with Volkswagen's PowerCo, replacing a cost-reimbursement model with milestone-based payments totaling up to $75.4 million. The amendment shifts focus to automotive cell development and larger format cells, and allows PowerCo to produce up to 500 MWh of demonstration fleet cells. This solidifies near-term funding and technical validation path, but the capped payments and revised milestones signal a more defined, potentially narrower, scope than the original open-ended collaboration.
At the time of this filing, QS was trading at $5.95 on NASDAQ in the Manufacturing sector, with a market capitalization of approximately $3.6B. The 52-week trading range was $5.65 to $19.07. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.